Market Access Strategy
Complete and extensive reimbursement strategy for Health Technology Assessment and Payer submissions
New Product Planning
Detailed market access assessments for new product planning including environment scan of the healthcare system, disease and therapeutic review.
Writing
Concise and impactful written documents for Health technology assessment dossiers, pharmaceutical marketing and training materials.
Shannon has diverse experience working in several major biopharmaceutical companies, with extensive knowledge of the market access environment in Canada.
With a background in market access, pricing, new product planning, and medical information, Shannon has a strong foundation of healthcare experience to bring to each of her engagements. This is complemented by her therapeutic and evidence based expertise as a pharmacist.
Shannon is a pharmacist and holds a BSc in Pharmacy from the University of British Columbia, a MSc in Neuroscience from the University of Western Ontario, as well as a BSc in Biomedical Sciences from the University of Guelph.
-
EducationBSc Biomedical Science, University of Guelph, MSc Neuroscience, Western University, BSc Pharmacy, University of British Columbia, Industrial Pharmacy Residency, University of Toronto
Eli LillyDevelop and convey customized scientific information to healthcare professionals, patients, and sales and marketing departments.
Eli LillyHealth Technology Assessment (HTA) strategy and dossier development for Health Canada approved medications and new product planning for pipeline assets.
ActavisDevelop and execute market access strategy from HTA submission to product listing negotiations with payers.
AllerganCreate patient and thought leader advocacy plans to support new product launch; Lead novel Pharmacy initiatives to ensure optimal patient access to medication and care.
